|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 233.70 EUR | -1.48% |
|
-7.09% | -0.08% |
| 07-13 | Antengene Receives $60 Million Milestone in UCB Licensing Deal | MT |
| 07-09 | UK Life Sciences Hits GBP3 Billion Investment Milestone | MT |
| Market Cap | 44.85B 51.13B 41.54B 38.22B 72.29B 4,894B 73.7B 495B 194B 2,403B 192B 188B 8,300B | P/E 2026 * |
25.5x | P/E 2027 * | 20.1x |
|---|---|---|---|---|---|
| Enterprise Value | 44.58B 50.82B 41.29B 37.99B 71.85B 4,865B 73.25B 492B 193B 2,389B 191B 187B 8,250B | EV / Sales 2026 * |
5.22x | EV / Sales 2027 * | 4.41x |
| Free-Float |
61.59% | Yield 2026 * |
0.62% | Yield 2027 * | 0.64% |
Last Transcript: UCB SA
| 1 day | -1.48% | ||
| 1 week | -7.09% | ||
| Current month | -9.88% | ||
| 1 month | -13.49% | ||
| 3 months | -13.81% | ||
| 6 months | -6.94% | ||
| Current year | -0.08% |
| 1 week | 235.9 |  | 252.3 |
| 1 month | 235.9 | | 268.5 |
| Current year | 224.8 | | 288.6 |
| 1 year | 169.7 | | 288.6 |
| 3 years | 66.04 | | 288.6 |
| 5 years | 66.04 | | 288.6 |
| 10 years | 59.48 | | 288.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 2014-12-31 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 59 | 2020-06-30 |
Alistair Henry
CTO | Chief Tech/Sci/R&D Officer | 59 | 2024-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 2011-12-31 | |
| Director/Board Member | 67 | 2014-12-31 | |
| Director/Board Member | 56 | 2014-04-23 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.48% | -7.09% | - | - | 51.13B | |
| -0.22% | +2.04% | +16.79% | -8.03% | 67.46B | |
| +0.36% | +40.00% | +40.00% | +40.00% | 43.4B | |
| +1.34% | -0.81% | -49.11% | -52.89% | 40.32B | |
| +4.96% | +0.27% | +55.75% | -24.80% | 30.86B | |
| -1.85% | -18.08% | +99.20% | -47.07% | 26.59B | |
| -2.12% | -1.20% | +66.54% | +84.42% | 22.82B | |
| +1.07% | +3.27% | +9.82% | +177.50% | 19.79B | |
| -0.76% | -4.50% | +55.11% | +125.27% | 16.47B | |
| -3.27% | +6.86% | +78.78% | +379.95% | 16.29B | |
| Average | +0.26% | -2.04% | +41.43% | +74.93% | 31.56B | |
| Weighted average by Cap. | +0.33% | -1.70% | +32.22% | +37.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.53B 9.73B 7.9B 7.27B 13.76B 931B 14.02B 94.2B 36.95B 457B 36.53B 35.74B 1,579B | 9.63B 10.98B 8.92B 8.21B 15.53B 1,051B 15.83B 106B 41.71B 516B 41.25B 40.35B 1,783B |
| Net income | 1.75B 2B 1.62B 1.49B 2.82B 191B 2.88B 19.33B 7.58B 93.83B 7.5B 7.33B 324B | 2.27B 2.59B 2.11B 1.94B 3.66B 248B 3.74B 25.1B 9.84B 122B 9.73B 9.52B 421B |
| Net Debt | -271M -309M -251M -231M -437M -29.6B -446M -2.99B -1.17B -14.54B -1.16B -1.14B -50.21B | -2.31B -2.64B -2.14B -1.97B -3.73B -252B -3.8B -25.53B -10.01B -124B -9.9B -9.69B -428B |
| Date | Price | Change |
|---|---|---|
| 26-07-09 | €237.20 | -5.27% |
| 26-07-13 | €235.90 | -0.55% |
| 26-07-10 | €237.20 | -5.27% |
| 26-07-09 | €250.40 | +0.81% |
| 26-07-08 | €248.40 | -2.05% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- UCB Stock
- UCB Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
